Cargando…

Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro

OBJECTIVES: Bladder transitional cell carcinoma (TCC) is one of the most common solid malignancies in China. This study examined the antitumor effect and underlying mechanism of action of sunitinib malate in human bladder TCC in vitro. METHODS: Bladder TCC cell lines 5637 and BIU87 were maintained i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jin, Li, Han-Zhong, Ji, Zhi-Gang, Jin, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350454/ https://www.ncbi.nlm.nih.gov/pubmed/25745360 http://dx.doi.org/10.1186/s12935-015-0179-z

Ejemplares similares

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

Guillain-Barré Syndrome following Treatment with Sunitinib Malate
por: Kanaan, Ziad, et al.
Publicado: (2014)

Preoperative therapy with sunitinib malate in a patient with a gastrointestinal stromal tumor and liver metastases: A case report
por: Wang, Zhi-Qiang, et al.
Publicado: (2019)

Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells
por: Yoon, Cheol Yong, et al.
Publicado: (2011)

ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd(+2) and As(+3) and in specimens of normal human urothelium and urothelial cancer
por: Ajjimaporn, Amornpan, et al.
Publicado: (2012)

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients
por: Numakura, Kazuyuki, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis
por: Li, Juan, et al.
Publicado: (2018)

Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis
por: Bao, Yuhai, et al.
Publicado: (2019)

Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
por: Watanabe, Koichiro, et al.
Publicado: (2010)

Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma
por: Shang, Donghao, et al.
Publicado: (2021)

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus
por: Lin, Chen-Sheng, et al.
Publicado: (2021)

Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines
por: Arantes-Rodrigues, Regina, et al.
Publicado: (2013)

Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297
por: Li, Jijun, et al.
Publicado: (2017)

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2009)

Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
por: Jou, Yeong-Chin, et al.
Publicado: (2021)

Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
por: Wu, Xianbin, et al.
Publicado: (2021)

Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro
por: Hoffmann, Katrin, et al.
Publicado: (2011)

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma
por: Wang, Jiawu, et al.
Publicado: (2019)

Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis
por: Peng, Ningfu, et al.
Publicado: (2020)

Ethanol extract of Ligustrum lucidum Ait. leaves suppressed hepatocellular carcinoma in vitro and in vivo
por: Tian, Guoyan, et al.
Publicado: (2019)

Tumor cell response to bevacizumab single agent therapy in vitro
por: Hein, Melanie, et al.
Publicado: (2013)

A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma
por: Li, Xinyuan, et al.
Publicado: (2022)

LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells
por: Li, Dechao, et al.
Publicado: (2020)

The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2020)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
por: Jin, Ya-Nan, et al.
Publicado: (2021)

Differences in the epigenetic regulation of MT-3 gene expression between parental and Cd(+2 )or As(+3 )transformed human urothelial cells
por: Somji, Seema, et al.
Publicado: (2011)

The expression of protease-activated receptors in esophageal carcinoma cells: the relationship between changes in gene expression and cell proliferation, apoptosis in vitro and growing ability in vivo
por: Jiang, Ping, et al.
Publicado: (2018)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate
por: O’Farrell, Alice C., et al.
Publicado: (2017)

miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition
por: Huang, Shirui, et al.
Publicado: (2021)

MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth
por: Zhu, Jin-Feng, et al.
Publicado: (2018)

Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis
por: Zhu, Baocheng, et al.
Publicado: (2021)

Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells
por: Fan, Changru, et al.
Publicado: (2020)

Transfection of oral squamous cell carcinoma with human papillomavirus-16 induces proliferative and morphological changes in vitro
por: Kingsley, Karl, et al.
Publicado: (2006)

Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro
por: Mochalski, Paweł, et al.
Publicado: (2013)

Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach
por: Ahmed, Mohammed Muqtader, et al.
Publicado: (2022)

Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle and spectrophotometric detection
por: Pourbasheer, Eslam, et al.
Publicado: (2023)

Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway
por: Liao, Xiao-Zhong, et al.
Publicado: (2017)

The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis
por: Zhao, Chengpeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kngg9q2duueugh07s7pom82b6